Morning Market Losers

shares dipped 26.03 percent to $2.16 after the company reported Phase 2 Rainier study results related to previously untreated metastatic pancreatic cancer.

dropped 12.49 percent to $3.79. On Tuesday, Cemtrex reported that it is seeing a surge in demand for its IS 2500 Multi Gas Analyzer.

fell 6.80 percent to $56.51. Analysts at Wedbush maintain their Outperform rating for Pacira Pharmaceuticals.

shares declined 5.88 percent to $3.68. Baytex Energy shares have dipped 90.00 percent over the past 52 weeks, while the S&P 500 index has slipped 2.78 percent in the same period.

shares dropped 5.07 percent to $9.38.

shares slipped 2.48 percent to $58.27. Oppenheimer downgraded CarMax from Outperform to Perform.